Search Results

Disclosure Ref 2025135 - Number of blood trests at Ripley Hospital.pdf

FOI Disclosure ref 2025135 regarding the total number of individual patient blood tests conducted by Ripley hospital per year for the 10-year period of 2015 to 2024

RAG Rating A3 (G320)

RAG Rating

Disclosure Ref 2024225 - Neonatal Abstinence Syndrome (NAS).pdf

Freedom of Information disclosure reference 2024225 relating to Neonatal Abstinence Syndrome (NAS).

Disclosure Ref 2024241 - Maternity services.pdf

Freedom of information disclosure reference 2024241 relating to contact details for DCHS maternity services

Disclosure Ref 2024255 - Data Breaches 2021 to 2024 .pdf

Freedom of Information request relating to the number of data breaches reported to the Information Commissioner’s Office and the total number of claims

Disclosure Ref 2025213 - Cyber security incidents, data breaches following cyber incidents & measures in place.doc

Freedom of Information disclosure relating to cyber security incidents, data breaches following cyber incidents & measures in place

Intravenous Therapy and Vascular Access Device (VAD) Policy - Adults (P47)

The use of intravenous medicines has many healthcare benefits for patients. Intravenous medicines are increasingly commonplace within the community setting and the need for an intravenous medicine is often a reason for patient’s being admitted to secondary care. Following the implementation of national and local policy, there is a new direction for community care providers such as DCHS to develop services that can be provided within the community hospital or community setting to accommodate patient’s being able to receive more complex care. The aims of this policy are: To prevent unnecessary acute hospital admission and to facilitate early discharge from the acute hospital setting by enabling patients to receive IV medicines safely within their own home or a community health care setting. To ensure an IV medicine is the most appropriate treatment for the patient and that it is administered via the most appropriate Vascular Access Device, the most appropriate vascular access site is chosen and the IV medicine is administered at the right time. To reduce the risk of complications by ensuring registered practitioners’ practice safely and consistently in relation to the administration of IV medicines, Vascular Access Device Insertion and the care and maintenance of Vascular Access Devices (VADs), through the implementation of evidence-based practice and by providing staff with the necessary guidance on clinical practice and training. To preserve and promote patient vessel health in the short and long term by ensuring any Vascular Access Device inserted is the most appropriate device for the treatment being administered and that it is placed by the most appropriately qualified practitioner.

Ward-Decoration-Guidelines.docx

Christmas 2021 - IP&C guidance

DCHS Community Podiatry eligibility leaflet (2020).pdf

DCHS Community Podiatry eligibility leaflet (2020)

Community services visiting you at home _1.pdf